Use access key #2 to skip to page content.
$0.39 -0.01 (-2.56%)
7/3/2008 12:55 PM

Memory Pharmaceuticals Corp. (MEMY)

CAPS Rating:
*****

A biopharmaceutical company focuses on the discovery and development of innovative drug candidates for the treatment of a range of central nervous system conditions.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

MEMY doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

80 Outperforms
5 Underperforms
 

All-Stars

15 Outperforms
1 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Players bullish on MEMY are also bullish on:

Players bearish on MEMY are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (293), Rule Breakers Universe (161)
Suggest a tag

Memory Pharmaceuticals Corp. At A Glance

Current Price: $0.39
Last Trade Time: 7/3/2008 12:55 PM
Open: $0.00
Previous Close: $0.39
Daily Range: $0.38 - $0.41
52-Week Range: $0.30 - $2.53
Volume: 5,150
Market Cap: $28.36M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

MEMY VS S&P 500 (SPY)

MEMY 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

3

Memory Pharmaceuticals Corp. (MEMY)

Avatar zzlangerhans (70.51) Submitted: 10/01/07 9:10 PM

This is a high risk speculative play made attractive by a relatively low market cap. The company has phase II data for two different compounds for Alzheimer's coming out in 4th quarter 2007. If just one of these is positive, the stock will finish the year significantly higher than its current price....More

Replies: 1 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 15 :   1 2 3 Next »

Show Pitch Replies

Recs

0

 (MEMY)

Avatar TraderMikeSays (< 20) Submitted: 10/15/07 9:42 AM : Outperform Start Price: $1.81 MEMY Score: -60.15

Ouchie, too late to sell this now. This poor stock has already been languishing at too low a price. Definitely oversold now, but should I increase my position?!!

Report this Post Replies: 1 | Reply | Permalink

Recs

3

 (MEMY)

Avatar zzlangerhans (70.51) Submitted: 10/01/07 9:10 PM : Outperform Start Price: $1.81 MEMY Score: -60.15

This is a high risk speculative play made attractive by a relatively low market cap. The company has phase II data for two different compounds for Alzheimer's coming out in 4th quarter 2007. If just one of these is positive, the stock will finish the year significantly higher than its current price. If you review unprofitable small cap biotechs, you won't find many with that kind of pipeline and a market cap below 200M. Alzheimer's has a long track record of upending small cap biotechs, but remember this is phase II data and not phase III. In now and then out after the phase II data, either way.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (MEMY)

Avatar FrtPilot (< 20) Submitted: 7/13/07 4:05 PM : Outperform Start Price: $2.30 MEMY Score: -64.54

Just for fun, watch this one!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MEMY)

Avatar AtomicDoom (94.37) Submitted: 7/01/07 6:58 PM : Underperform Start Price: $2.38 MEMY Score: 67.33

Terrible fundamentals. Am I missing something here?

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (MEMY)

Avatar TWISBWM (34.74) Submitted: 5/17/07 12:24 AM : Outperform Start Price: $2.30 MEMY Score: -66.48

My first attempt at buying in bulk strictly for the profit. Hoping it pans out as well as expected.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 15 :   1 2 3 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackFortisBank 98.77 01/18/07 Outperform NS $3.76-89.63%-11.78%-77.85

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEB20 1063ms